; virus seeds; clinical trial lots; novel virus strains; and antigen and adjuvant material); ; (2) in subsection (d)(2), by striking $611,700,000 for each of fiscal years 2019 through 2023 and inserting $950,000,000 for each of fiscal years 2024 through 2028 ; and (3) in subsection (e)(1), by amending subparagraph (D) to read as follows: (D) Sunset This paragraph shall cease to have force or effect after September 30, 2028. . 208. Public Health Emergency Medical Countermeasures Enterprise Section 2811–1(c) of the Public Health Service Act (42 U.S.C. 300hh–10a(c)) is amended— (1) in paragraph (1)— (A) by redesignating subparagraph (D) as subparagraph (E); and (B) by inserting after subparagraph (C) the following: (D) Assist the Secretary in developing strategies for appropriate and evidence-based allocation and distribution of countermeasures to jurisdictions, in a manner that supports the availability and use of such countermeasures, for public health and medical preparedness and response needs. ; (2) in paragraph (2), by striking , as appropriate